Nurix Therapeutics Income Statement (2019-2026) | NRIX

Income Statement May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Revenue & cost
Revenue (Quarter) 9.44M10.58M1.86M2.86M4.18M4.08M6.69M5.01M7.09M10.25M7.40M9.62M11.43M10.79M6.78M12.69M30.68M18.47M15.16M16.59M12.09M12.59M20.00M18.45M15.00M7.89M6.25M
Operating items
Research & Development (Quarter) 11.01M12.82M12.97M14.14M18.94M20.45M23.00M25.99M30.91M36.53M43.14M47.49M47.76M46.11M45.82M45.76M47.86M49.71M50.01M48.92M55.48M67.22M69.66M78.10M86.12M83.02M84.14M
Selling, General & Administrative (Quarter) 2.18M2.60M2.45M3.27M4.34M6.25M6.53M7.51M8.34M8.82M9.23M9.65M9.75M9.37M9.82M11.68M10.62M10.78M11.80M11.71M11.72M10.72M11.65M14.28M13.16M13.65M14.61M
Operating Expenses (Quarter) 13.19M15.43M15.42M17.41M23.28M26.70M29.53M33.51M39.25M45.35M52.37M57.15M57.51M55.47M55.64M57.44M58.48M60.49M61.80M60.63M67.20M77.94M81.32M92.38M99.28M96.67M98.75M
Operating Income (Quarter) -2.61M-13.56M-12.55M-13.23M-19.19M-20.01M-24.52M-26.41M-29.00M-37.95M-42.74M-45.72M-46.72M-48.69M-42.95M-26.77M-40.01M-45.33M-45.22M-48.54M-54.61M-64.66M-62.86M-48.32M-91.39M-83.09M-92.50M
EBIT (Quarter) -2.61M-13.56M-12.55M-13.23M-19.19M-20.01M-24.52M-26.41M-29.00M-37.95M-42.74M-45.72M-46.72M-48.69M-42.95M-26.77M-40.01M-45.33M-45.22M-48.54M-54.61M-64.66M-62.86M-48.32M-91.39M-83.09M-92.50M
Non-operating items
Interest & Investment Income (Quarter) 0.20M0.26M0.17M0.22M0.68M0.14M0.32M0.17M0.04M0.29M0.21M0.31M1.01M1.97M2.22M2.49M3.03M3.38M3.79M4.08M5.74M6.12M6.51M5.62M4.96M4.87M5.32M
Net income details
EBT (Quarter) -2.42M-13.31M-12.38M-13.01M-18.52M-19.87M-24.20M-26.24M-28.96M-37.66M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.43M-44.46M-48.87M-58.54M-56.35M-42.70M-86.42M-78.22M-87.17M
Tax Provisions (Quarter) 0.01M-0.03M0.01M-20.59M0.08M0.07M0.10M-0.12M0.04M0.09M0.09M0.08M0.01M0.76M
Profit After Tax (Quarter) -3.07M-2.43M-13.52M-12.39M7.58M-18.52M-19.91M-24.27M-26.38M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Income from Continuing Operations (Quarter) -2.43M-13.28M-12.39M7.58M-18.52M-19.95M-24.27M-26.34M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Consolidated Net Income (Quarter) -2.43M-13.28M-12.39M7.58M-18.52M-19.95M-24.27M-26.34M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Income towards Parent Company (Quarter) -2.43M-13.28M-12.39M7.58M-18.52M-19.95M-24.27M-26.34M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Net Income towards Common Stockholders (Quarter) -2.43M-13.28M-12.39M7.58M-18.52M-19.95M-24.27M-26.34M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Additional items
EPS (Basic) (Quarter) -0.89-0.66-3.55-3.502.03-1.09-0.51-0.63-0.60-0.65-0.85-0.95-1.01-0.90-0.86-0.75-0.45-0.68-0.77-0.76-0.71-0.67-0.75-0.67-0.52-1.03-0.83-0.79
EPS (Weighted Average and Diluted) (Quarter) -0.60-0.65-0.85-0.95-1.01-0.90-0.86-0.75-0.45-0.68-0.77-0.76-0.71-0.67-0.75-0.67-0.52-1.03-0.83-0.79
Shares Outstanding (Weighted Average) (Quarter) 3.43M3.67M3.29M3.54M3.73M16.94M15.67M38.78M41.32M44.37M42.90M44.69M44.80M46.84M48.61M54.03M54.14M54.23M54.34M54.90M62.38M63.38M67.12M83.56M83.72M83.87M86.67M110.07M
Shares Outstanding (Diluted Average) (Quarter) 43.80M42.34M42.90M44.69M44.90M46.84M48.61M54.03M54.14M54.23M54.34M54.90M62.38M63.38M67.12M83.56M83.72M84.16M86.67M110.07M
EBITDA (Quarter) -2.61M-13.56M-12.55M-13.23M-19.19M-20.01M-24.52M-26.41M-29.00M-37.95M-42.74M-45.72M-46.72M-48.69M-42.95M-26.77M-40.01M-45.33M-45.22M-48.54M-54.61M-64.66M-62.86M-48.32M-91.39M-83.09M-92.50M
Tax Rate (Quarter) -0.41%0.21%-0.09%158.28%-0.38%-0.29%-0.38%0.42%-0.12%-0.22%-0.20%-0.17%-0.01%-1.78%